Heart Rhythm
Volume 7, Issue 7 , Pages 876-882 , July 2010

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis

  • Pasquale Santangeli, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Pasquale Santangeli, Cardiology Department, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • Gemma Pelargonio, MD, PhD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • ,
  • Antonio Dello Russo, MD, PhD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • ,
  • Michela Casella, MD, PhD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • ,
  • Caterina Bisceglia, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • ,
  • Stefano Bartoletti, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • ,
  • Pietro Santarelli, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • ,
  • Luigi Di Biase, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • Department of Cardiology, University of Foggia, Foggia, Italy
    • Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas
    • ,
  • Andrea Natale, MD, FHRS

      Affiliations

    • Department of Biomedical Engineering, University of Texas, Austin, Texas
    • Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas

Received 28 December 2009 ,Accepted 31 March 2010.

References 

  1. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350–e408
  2. Albert CM, Quigg R, Saba S, et al. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. Am Heart J. 2008;156:367–372
  3. Russo AM, Poole JE, Mark DB, et al. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol. 2008;19:720–724
  4. Russo AM, Stamato NJ, Lehmann MH, et al. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol. 2004;15:993–998
  5. Zareba W, Moss AJ, Jackson Hall W, et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005;16:1265–1270
  6. Curtis LH, Al-Khatib SM, Shea AM, et al. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517–1524
  7. Russo AM, Day JD, Stolen K, et al. Implantable cardioverter defibrillators: do women fare worse than men? (Gender comparison in the INTRINSIC RV trial). J Cardiovasc Electrophysiol. 2009;20:973–978
  8. Ghanbari H, Dalloul G, Hasan R, et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169:1500–1506
  9. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.1, updated September 2008, The Cochrane Collaboration, 7.7.7.2. http://www.cochrane-handbook.org
  10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  11. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (Quality of reporting of meta-analyses). Lancet. 1999;354:1896–1900
  12. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488
  13. Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427–1436
  14. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150
  15. Saxon LA, Bristow MR, Boehmer J, et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006;114:2766–2772
  16. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  17. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease (Multicenter Unsustained Tachycardia Trial Investigators). N Engl J Med. 1999;341:1882–1890
  18. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–2158
  19. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  20. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111–1121
  21. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?. Am J Cardiol. 2006;97:1255–1261
  22. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136:205–212
  23. Spain DM, Bradess VA, Mohr C. Coronary atherosclerosis as a cause of unexpected and unexplained death (An autopsy study from 1949–1959). JAMA. 1960;174:384–388
  24. Aronson D, Burger AJ. The effect of sex on ventricular arrhythmic events in patients with congestive heart failure. Pacing Clin Electrophysiol. 2002;25:1206–1211
  25. Dolack GL. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial) (Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation). Am J Cardiol. 1994;73:237–241
  26. Lampert R, McPherson CA, Clancy JF, et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol. 2004;43:2293–2299
  27. Wilber DJ, Zareba W, Hall WJ, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004;109:1082–1084
  28. Russo AM, Hafley GE, Lee KL, et al. Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks. Circulation. 2003;108:67–72

 Dr. Natale has received compensation for belonging to the speakers' bureau for St. Jude Medical, Boston Scientific, Medtronic, and Biosense Webster and has received a research grant from St. Jude Medical.

PII: S1547-5271(10)00336-X

doi: 10.1016/j.hrthm.2010.03.042

Heart Rhythm
Volume 7, Issue 7 , Pages 876-882 , July 2010

Article Tools

* Image Usage & Resolution